Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2002
10/02/2002EP1245681A2 A method for the production of pharmaceutically active recombinant proteins comprising the use of alkanoic acids, their derivatives or salts thereof
10/02/2002EP1245564A1 Benzamidine derivatives
10/02/2002EP1245229A2 Methods and compositions for inhibition of angiogenesis
10/02/2002EP1244793A2 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same
10/02/2002EP1244701A1 Transferrin polynucleotides, polypeptides, and antibodies
10/02/2002EP1244700A2 Vesicle trafficking proteins
10/02/2002EP1244683A1 21 human secreted proteins
10/02/2002EP1244673A2 Novel imidazo 1,3,5]triazinones and the use thereof
10/02/2002EP1244669A1 Pyrazolopyrazines and their use as adenosine antagonists
10/02/2002EP1244657A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin
10/02/2002EP1244640A1 Oxazolidinone derivatives
10/02/2002EP1244636A1 Benzimidazoles, production thereof and the use thereof as antithrombotic
10/02/2002EP1244628A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
10/02/2002EP1244626A2 Caspase inhibitors and uses thereof
10/02/2002EP1244616A1 (hetero)bicyclylmethanesulfonylamino-substituted hydroxamic acid derivatives
10/02/2002EP1244461A2 INHIBITION OF GSK-3$g(b)
10/02/2002EP1244446A1 Thrombopoietin mimetics
10/02/2002EP1244427A2 Pharmaceutical compositions for oral administration
10/02/2002EP1123103B1 A process for producing an iron-dextran compound
10/02/2002EP0984787B1 Use of low-molecular-weight heparins for preventing and treating cerebral edemas
10/02/2002EP0793503B1 Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells
10/02/2002EP0792281B1 Process for purification of factor viii
10/02/2002DE10115945A1 Substituierte 2-Carba-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and their use
10/02/2002DE10115740A1 Zubereitung für die Restenoseprophylaxe Preparation for the prophylaxis of restenosis
10/02/2002DE10115408A1 Benzofuran-Derivate Benzofuran derivatives
10/02/2002DE10112825A1 HESylierung von Wirkstoffen in wässriger Lösung HESylation of drugs in aqueous solution
10/02/2002CN1372569A Keratinocyte growth factor-2
10/02/2002CN1372562A Imidazoimidazoles and triazoles as anti-inflammatory agents
10/02/2002CN1372555A Compositions and therapeutic mehtods involving isoflavones and analogues thereof
10/02/2002CN1372474A Methods for preventing or attenuating patthoangiogenic conditions
10/02/2002CN1371740A Chinese medicine injection for treating acute cerebral hemorrhage and preparation method thereof
10/02/2002CN1371733A Naoan brain care capsule and preparation process thereof
10/02/2002CN1371728A Powder medicine for promoting blood circulation and removing blood stasis
10/02/2002CN1371717A Traditional Chinese medicine composition for treating ischemic cardio-verebral vascular disease and peripheral vascular disease
10/02/2002CN1371687A Hypoalbuminemia improvement agent
10/02/2002CN1091768C Novel benzo-1,3-dioxolyl-and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
10/01/2002US6459003 Ether compounds
10/01/2002US6458952 Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
10/01/2002US6458931 Immunoassay, immunotherapy; cancer; side effect reduction
10/01/2002US6458845 Macrophage scavenger receptor antagonists
10/01/2002US6458827 Adjustent of conformation equilibrium; active materials
10/01/2002US6458822 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/01/2002US6458810 Pharmaceutically active isoindoline derivatives
10/01/2002US6458796 Method of treating cardiovascular disorders, thromboembolic disorders and ischaemias, and urogenital system disorders, comprising administering to mammals
10/01/2002US6458793 Heterocyclic derivatives which inhibit factor Xa
10/01/2002US6458586 Replication of defective vectors with mutations and deletions; gene therapy, vaccines, genetic engineering
10/01/2002US6458563 Dna which encodes protein of defined amino acid sequence; stable, less immunogenic treatment of hemophilia
10/01/2002US6458383 Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
10/01/2002US6458361 Soaking in water, heating beyond boiling point, stirring, filtering
10/01/2002US6458360 Soluble complement regulatory molecules
10/01/2002US6458147 Compositions, systems, and methods for arresting or controlling bleeding or fluid leakage in body tissue
10/01/2002CA2168113C Therapeutic peptide derivatives
10/01/2002CA2103546C Modified factor vii
09/2002
09/27/2002CA2378876A1 Cyclohexylamine derivatives as subtype selective n-methyl-d-aspartate antagonists
09/26/2002WO2002074970A1 A process for the production of an inhibitor of human platelet aggregation and soybean lipoxygenase
09/26/2002WO2002074913A2 Nucleic acid-associated proteins
09/26/2002WO2002074807A2 Chimpanzee erythropoietin (chepo) - immunoadhesins
09/26/2002WO2002074798A2 The genome of a bifidobacterium
09/26/2002WO2002074767A1 Metalloproteinase inhibitors
09/26/2002WO2002074765A1 Phenyl derivatives 3
09/26/2002WO2002074758A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications
09/26/2002WO2002074752A1 Metalloproteinase inhibitors
09/26/2002WO2002074751A1 Metalloproteinase inhibitors
09/26/2002WO2002074749A1 Metalloproteinase inhibitors
09/26/2002WO2002074748A1 Metalloproteinase inhibitors
09/26/2002WO2002074735A2 Biurethane derivatives
09/26/2002WO2002074346A2 Targeting chemical compounds to cells
09/26/2002WO2002074312A1 Pyrazolo`4,3-d.pyrimidinone compounds as cgmp pde inhibitors
09/26/2002WO2002074301A1 Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions
09/26/2002WO2002074292A2 Hormone replacement therapy
09/26/2002WO2002074291A2 Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor
09/26/2002WO2002074249A2 Pharmaceuticals and methods for treating hypoxia and screening methods therefor
09/26/2002WO2002074231A2 Cosmetic and dermopharmaceutical compositions comprising standardised extracts of hierochloe odorata
09/26/2002WO2002049665A3 Use of activated coagulation factor vii for treating thrombolytic therapy-induced major bleedings
09/26/2002WO2002038609A3 Apolipoprotein conjugates
09/26/2002WO2002032461A3 Protein c or activated protein c-like molecules
09/26/2002WO2002029084A3 Industrial-scale serum-free production of recombinant factor vii in mammalian cells
09/26/2002WO2002024666A3 4-amino-quinazolines
09/26/2002WO2002000710A3 B7-like molecules and uses thereof
09/26/2002WO2001098332A3 Secreted redox proteins
09/26/2002WO2001087343A3 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
09/26/2002WO2001083775A3 Proteases
09/26/2002WO2001073002A3 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides
09/26/2002WO2001052847A8 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
09/26/2002WO2001019977A9 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions
09/26/2002WO2001019823A9 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
09/26/2002US20020138857 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
09/26/2002US20020138038 Device and method for dispensing at least two mutually reactive components
09/26/2002US20020137894 Megakaryocyte stimulating factors
09/26/2002US20020137884 Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor
09/26/2002US20020137802 Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
09/26/2002US20020137775 Novel delta dicarbonyl compounds and methods for using the same
09/26/2002US20020137755 Tyrosine kinase inhibitors
09/26/2002US20020137742 Benzenesulfonamide compounds
09/26/2002US20020137686 Inhibitors of the ICE/ced-3 family of cysteine proteases
09/26/2002US20020137221 Method of preserving oxygen infusions
09/26/2002US20020137202 Diagnosis, treatment, and prevention of disorders associated with a FCTRX nucleic acid, polypeptide, or an antibody specific for it
09/26/2002US20020136819 Conserved concentrations of cocoa polyphenols by mixing carbohydrate or protein containing ingredients with a polyphenol conserving pretreatment ingredient and then with a cocoa polyphenol
09/26/2002US20020136775 Aldosterone receptor blockers
09/26/2002US20020136726 Method for selectively delivering agent to arterial smooth muscle cells in mammal comprising administering agent and substance which selectively binds arterial smooth muscle cell-specific surface molecule selected from ephrin family
1 ... 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 ... 671